Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

NATerminatedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

September 28, 2020

Study Completion Date

September 28, 2020

Conditions
LymphomaLung CancerColo-rectal Cancer
Interventions
OTHER

SMARTCare

"1. Ambulatory nurses will undertake 4 hours of training consistent with the evidenced-based guidelines for SMS in routine care.~2. An education program for patients in the intervention arm that targets training in core self-management skills and is comprised of an introduction and 5 education modules.~3. An introductory call from a health coach prior to initiating treatment and 5 subsequent calls: prior to the first dose of treatment; 7-14 days following the first dose of treatment; within 2 weeks of coaching session 2; and timing is flexible for the last 2 sessions, but to be completed within 4 months following the first dose of treatment.~4. Optional sub-study: A sub-set of patients will participate in an end of study interview to gain further insight into SMARTCare."

OTHER

Control

1\. Ambulatory nurses will undertake 4 hours of training consistent with the evidenced-based guidelines for SMS in routine care.

Trial Locations (3)

L4M6M2

Royal Victoria Regional Health Centre, Barrie

L8V5C2

Hamilton Health Sciences Corporation, Hamilton

M5G2M9

Princess Margaret Cancer Centre, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Care Ontario

OTHER

lead

University Health Network, Toronto

OTHER

NCT03849950 - Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare) | Biotech Hunter | Biotech Hunter